ArticleNeuro-oncology2013

Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.

Christine Lu-Emerson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.